MEK1/2 inhibition decreases pro-inflammatory responses in macrophages from people with cystic fibrosis and mitigates severity of illness in experimental murine methicillin-resistant Staphylococcus aureus infection is a research paper published in Frontiers in Cellular and Infection Microbiology (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cystic Fibrosis Foundation
Grant: LONG19F5-CI, LONG21R3, MCCOY19RO, SINGH15RO, MANICO19G0
National Institutes of Health
Grant: HL144656, HL136786, AI146141, HL167956
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
National Institutes of Health
Grant: 5R01HL144656-02
Macrophage Signaling Pathways in Acute Lung Injury and Resolution
National Institutes of Health
Grant: 5R01HL167956-03
GM-CSF, macrophages, and susceptibility to Mycobacterium abscessus pulmonary infection
National Institutes of Health
Grant: 1K08HL136786-01A1
Modulating macrophage-mediated inflammation in cystic fibrosis
National Institutes of Health
Grant: 1K22AI146141-01A1
Mechanisms of Interferon-Lambda Programming at the Innate-Adaptive Immune Interface for Protection Against Virus Infection
National Institutes of Health
Grant: 5UL1TR002733-02
The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
Fields of Study
Keywords
Sustainable Development Goals